A total of 4 analyst ratings have been received for Sage Therapeutics, with the consensus rating being Neutral. The average one-year price target stands at $9.5, suggesting a potential 21.95% upside.

Vanguard S&P 500 ETF remains a strong investment despite inflation fears and tariffs. Click here to find out why VOO ETF is a ...